UniProt ID | RTEL1_HUMAN | |
---|---|---|
UniProt AC | Q9NZ71 | |
Protein Name | Regulator of telomere elongation helicase 1 {ECO:0000255|HAMAP-Rule:MF_03065} | |
Gene Name | RTEL1 {ECO:0000255|HAMAP-Rule:MF_03065} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1219 | |
Subcellular Localization | Nucleus . Colocalizes with PCNA within the replication foci in S-phase cells. | |
Protein Description | ATP-dependent DNA helicase implicated in telomere-length regulation, DNA repair and the maintenance of genomic stability. Acts as an anti-recombinase to counteract toxic recombination and limit crossover during meiosis. Regulates meiotic recombination and crossover homeostasis by physically dissociating strand invasion events and thereby promotes noncrossover repair by meiotic synthesis dependent strand annealing (SDSA) as well as disassembly of D loop recombination intermediates. Also disassembles T loops and prevents telomere fragility by counteracting telomeric G4-DNA structures, which together ensure the dynamics and stability of the telomere.. | |
Protein Sequence | MPKIVLNGVTVDFPFQPYKCQQEYMTKVLECLQQKVNGILESPTGTGKTLCLLCTTLAWREHLRDGISARKIAERAQGELFPDRALSSWGNAAAAAGDPIACYTDIPKIIYASRTHSQLTQVINELRNTSYRPKVCVLGSREQLCIHPEVKKQESNHLQIHLCRKKVASRSCHFYNNVEEKSLEQELASPILDIEDLVKSGSKHRVCPYYLSRNLKQQADIIFMPYNYLLDAKSRRAHNIDLKGTVVIFDEAHNVEKMCEESASFDLTPHDLASGLDVIDQVLEEQTKAAQQGEPHPEFSADSPSPGLNMELEDIAKLKMILLRLEGAIDAVELPGDDSGVTKPGSYIFELFAEAQITFQTKGCILDSLDQIIQHLAGRAGVFTNTAGLQKLADIIQIVFSVDPSEGSPGSPAGLGALQSYKVHIHPDAGHRRTAQRSDAWSTTAARKRGKVLSYWCFSPGHSMHELVRQGVRSLILTSGTLAPVSSFALEMQIPFPVCLENPHIIDKHQIWVGVVPRGPDGAQLSSAFDRRFSEECLSSLGKALGNIARVVPYGLLIFFPSYPVMEKSLEFWRARDLARKMEALKPLFVEPRSKGSFSETISAYYARVAAPGSTGATFLAVCRGKASEGLDFSDTNGRGVIVTGLPYPPRMDPRVVLKMQFLDEMKGQGGAGGQFLSGQEWYRQQASRAVNQAIGRVIRHRQDYGAVFLCDHRFAFADARAQLPSWVRPHVRVYDNFGHVIRDVAQFFRVAERTMPAPAPRATAPSVRGEDAVSEAKSPGPFFSTRKAKSLDLHVPSLKQRSSGSPAAGDPESSLCVEYEQEPVPARQRPRGLLAALEHSEQRAGSPGEEQAHSCSTLSLLSEKRPAEEPRGGRKKIRLVSHPEEPVAGAQTDRAKLFMVAVKQELSQANFATFTQALQDYKGSDDFAALAACLGPLFAEDPKKHNLLQGFYQFVRPHHKQQFEEVCIQLTGRGCGYRPEHSIPRRQRAQPVLDPTGRTAPDPKLTVSTAAAQQLDPQEHLNQGRPHLSPRPPPTGDPGSQPQWGSGVPRAGKQGQHAVSAYLADARRALGSAGCSQLLAALTAYKQDDDLDKVLAVLAALTTAKPEDFPLLHRFSMFVRPHHKQRFSQTCTDLTGRPYPGMEPPGPQEERLAVPPVLTHRAPQPGPSRSEKTGKTQSKISSFLRQRPAGTVGAGGEDAGPSQSSGPPHGPAASEWGL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
35 | Ubiquitination | VLECLQQKVNGILES HHHHHHHHHCCCCCC | 25.38 | - | |
120 | Phosphorylation | SRTHSQLTQVINELR CCCHHHHHHHHHHHH | 17.10 | - | |
134 | Ubiquitination | RNTSYRPKVCVLGSR HCCCCCCCEEEECCH | 38.99 | - | |
171 | Phosphorylation | RKKVASRSCHFYNNV HHHHHHCCCCCCCCC | 14.95 | 30576142 | |
175 | Phosphorylation | ASRSCHFYNNVEEKS HHCCCCCCCCCCCHH | 5.12 | 19664995 | |
199 | Ubiquitination | LDIEDLVKSGSKHRV CCHHHHHHCCCCCCC | 57.29 | - | |
209 | Phosphorylation | SKHRVCPYYLSRNLK CCCCCHHHHHHCCHH | 16.35 | - | |
210 | Phosphorylation | KHRVCPYYLSRNLKQ CCCCHHHHHHCCHHH | 5.37 | - | |
216 | Ubiquitination | YYLSRNLKQQADIIF HHHHCCHHHHCCEEE | 43.86 | - | |
233 | Ubiquitination | YNYLLDAKSRRAHNI HHHHHCCHHHHCCCC | 44.13 | - | |
274 | Phosphorylation | LTPHDLASGLDVIDQ CCHHHHHHCHHHHHH | 47.38 | 22210691 | |
300 | Phosphorylation | GEPHPEFSADSPSPG CCCCCCCCCCCCCCC | 29.51 | 30624053 | |
303 | Phosphorylation | HPEFSADSPSPGLNM CCCCCCCCCCCCCCC | 27.30 | 30576142 | |
305 | Phosphorylation | EFSADSPSPGLNMEL CCCCCCCCCCCCCCH | 35.24 | 25159151 | |
347 | Phosphorylation | GVTKPGSYIFELFAE CCCCCCCHHHHHHEE | 18.62 | - | |
361 | Phosphorylation | EAQITFQTKGCILDS ECCEEEECCCHHHHC | 25.80 | - | |
405 | Phosphorylation | IVFSVDPSEGSPGSP EEEECCCCCCCCCCC | 50.56 | - | |
411 | Phosphorylation | PSEGSPGSPAGLGAL CCCCCCCCCCCCCCC | 18.24 | - | |
543 | Ubiquitination | ECLSSLGKALGNIAR HHHHHHHHHHHHHHH | 45.81 | - | |
543 (in isoform 2) | Ubiquitination | - | 45.81 | - | |
554 | Phosphorylation | NIARVVPYGLLIFFP HHHHHCCCCEEEEEC | 14.59 | 27174698 | |
562 | Phosphorylation | GLLIFFPSYPVMEKS CEEEEECCCCHHHHH | 36.59 | 27174698 | |
563 | Phosphorylation | LLIFFPSYPVMEKSL EEEEECCCCHHHHHH | 10.49 | 27174698 | |
569 | Phosphorylation | SYPVMEKSLEFWRAR CCCHHHHHHHHHHHH | 21.59 | 27174698 | |
586 | Ubiquitination | ARKMEALKPLFVEPR HHHHHHHHHCEECCC | 46.88 | - | |
595 | Ubiquitination | LFVEPRSKGSFSETI CEECCCCCCCHHHHH | 60.91 | - | |
626 | Ubiquitination | FLAVCRGKASEGLDF EEHHHCCCCCCCCCC | 29.41 | - | |
659 | Ubiquitination | MDPRVVLKMQFLDEM CCHHHHEEEEHHHHH | 21.03 | - | |
764 | Phosphorylation | PAPAPRATAPSVRGE CCCCCCCCCCCCCCH | 40.14 | 23312004 | |
767 | Phosphorylation | APRATAPSVRGEDAV CCCCCCCCCCCHHHH | 23.22 | 23312004 | |
775 | Phosphorylation | VRGEDAVSEAKSPGP CCCHHHHHHCCCCCC | 33.29 | 29978859 | |
778 | Ubiquitination | EDAVSEAKSPGPFFS HHHHHHCCCCCCCCC | 53.80 | - | |
779 | Phosphorylation | DAVSEAKSPGPFFST HHHHHCCCCCCCCCC | 41.98 | 25159151 | |
785 | Phosphorylation | KSPGPFFSTRKAKSL CCCCCCCCCCCCCCC | 27.90 | 29978859 | |
786 | Phosphorylation | SPGPFFSTRKAKSLD CCCCCCCCCCCCCCC | 30.91 | 29978859 | |
791 | Phosphorylation | FSTRKAKSLDLHVPS CCCCCCCCCCEECCC | 31.79 | 25159151 | |
798 | Phosphorylation | SLDLHVPSLKQRSSG CCCEECCCHHHCCCC | 47.30 | 23312004 | |
800 | Ubiquitination | DLHVPSLKQRSSGSP CEECCCHHHCCCCCC | 48.26 | - | |
803 | Phosphorylation | VPSLKQRSSGSPAAG CCCHHHCCCCCCCCC | 36.24 | 28985074 | |
804 | Phosphorylation | PSLKQRSSGSPAAGD CCHHHCCCCCCCCCC | 45.54 | 26657352 | |
806 | Phosphorylation | LKQRSSGSPAAGDPE HHHCCCCCCCCCCCC | 17.20 | 24719451 | |
815 | Phosphorylation | AAGDPESSLCVEYEQ CCCCCCCCCEEEECC | 24.91 | 24719451 | |
827 | Phosphorylation | YEQEPVPARQRPRGL ECCCCCCHHHCCHHH | 22.07 | 27251275 | |
830 | Phosphorylation | EPVPARQRPRGLLAA CCCCHHHCCHHHHHH | 19.82 | 24719451 | |
847 | Phosphorylation | HSEQRAGSPGEEQAH HHHHHCCCCCHHHHH | 28.84 | 23401153 | |
855 | Phosphorylation | PGEEQAHSCSTLSLL CCHHHHHCCHHHHHH | 16.87 | 29255136 | |
857 | Phosphorylation | EEQAHSCSTLSLLSE HHHHHCCHHHHHHCC | 35.08 | 29255136 | |
858 | Phosphorylation | EQAHSCSTLSLLSEK HHHHCCHHHHHHCCC | 25.37 | 29255136 | |
863 | Phosphorylation | CSTLSLLSEKRPAEE CHHHHHHCCCCCCCC | 46.49 | 24719451 | |
871 | Phosphorylation | EKRPAEEPRGGRKKI CCCCCCCCCCCCCEE | 31.55 | 24719451 | |
881 | Phosphorylation | GRKKIRLVSHPEEPV CCCEEEEEECCCCCC | 3.38 | 27251275 | |
882 | Phosphorylation | RKKIRLVSHPEEPVA CCEEEEEECCCCCCC | 37.61 | 28450419 | |
906 | Phosphorylation | FMVAVKQELSQANFA HHHHHHHHHHHCCHH | 44.67 | 24719451 | |
953 | Phosphorylation | HNLLQGFYQFVRPHH CCHHHHHHHHHCHHH | 14.10 | 23532336 | |
1103 | Phosphorylation | LAVLAALTTAKPEDF HHHHHHHHCCCHHHC | 21.71 | - | |
1104 | Phosphorylation | AVLAALTTAKPEDFP HHHHHHHCCCHHHCC | 33.27 | - | |
1180 | Acetylation | KTGKTQSKISSFLRQ CCCCCHHHHHHHHHC | 36.47 | 25953088 | |
1183 | Phosphorylation | KTQSKISSFLRQRPA CCHHHHHHHHHCCCC | 31.60 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RTEL1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RTEL1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RTEL1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MMS19_HUMAN | MMS19 | physical | 22678361 | |
RAD51_HUMAN | RAD51 | physical | 26496610 | |
VAV2_HUMAN | VAV2 | physical | 26496610 | |
FA13A_HUMAN | FAM13A | physical | 26496610 | |
GA2L1_HUMAN | GAS2L1 | physical | 26496610 | |
TEST_HUMAN | PRSS21 | physical | 26496610 | |
WDFY3_HUMAN | WDFY3 | physical | 26496610 | |
ANKL2_HUMAN | ANKLE2 | physical | 26496610 | |
AT132_HUMAN | ATP13A2 | physical | 26496610 | |
AATF_HUMAN | AATF | physical | 26496610 | |
NDUAD_HUMAN | NDUFA13 | physical | 26496610 | |
S18L2_HUMAN | SS18L2 | physical | 26496610 | |
EMSY_HUMAN | C11orf30 | physical | 26496610 | |
THA11_HUMAN | THAP11 | physical | 26496610 | |
CCYL1_HUMAN | CCNYL1 | physical | 26496610 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
615190 | Dyskeratosis congenita, autosomal recessive, 5 (DKCB5) | |||||
615190 | Dyskeratosis congenita, autosomal dominant, 4 (DKCA4) | |||||
616373 | Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 3 (PFBMFT3) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...